Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation.
暂无分享,去创建一个
Y. Surh | K. Chun | K. K. Park | Y. Keum | S. Lee | S. Han | S S Lee | Y J Surh | K K Park | K S Chun | H H Cha | S S Han | Y S Keum | Sang Sup Lee | H. Cha | Seongkyung Han | Young-Joon Surh | K. Park | Kyung-Soo Chun | Seong Su Han | Young-Sam Keum | Kwang Kyun Park | Sang Sup Lee | Kwang Kyun Park
[1] J. Xie,et al. Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. , 1997, Carcinogenesis.
[2] R. Carter,et al. Prostaglandin-like material extracted from squamous carcinomas of the head and neck. , 1980, British Journal of Cancer.
[3] G. Yang,et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. , 1998, Carcinogenesis.
[4] H. Ohshima,et al. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. , 1995, Biochemical and biophysical research communications.
[5] D. Gius,et al. Intracellular oxidation/reduction status in the regulation of transcription factors NF-kappaB and AP-1. , 1999, Toxicology letters.
[6] K. Seibert,et al. Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. , 2000, Cancer research.
[7] B. Dörken,et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.
[8] J. Vane,et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. Luther,et al. The Dietary Pigment Curcumin Reduces Endothelial Tissue Factor Gene Expression by Inhibiting Binding of AP-1 to the DNA and Activation of NF-κB , 1997, Thrombosis and Haemostasis.
[10] Quan Zhao,et al. Mitogen-activated Protein Kinase/ERK Kinase Kinases 2 and 3 Activate Nuclear Factor-κB through IκB Kinase-α and IκB Kinase-β* , 1999, The Journal of Biological Chemistry.
[11] W. Koppenol,et al. On the pH-dependent yield of hydroxyl radical products from peroxynitrite. , 1994, Free radical biology & medicine.
[12] S. Pizzo,et al. Aspirin inhibits tumor necrosis factoralpha gene expression in murine tissue macrophages. , 1997, Molecular pharmacology.
[13] H. Ichijo,et al. From receptors to stress-activated MAP kinases , 1999, Oncogene.
[14] H. Bartsch,et al. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. , 1994, Mutation research.
[15] A. Morrison,et al. Interleukin-1β-induced Cyclooxygenase-2 Expression Requires Activation of Both c-Jun NH2-terminal Kinase and p38 MAPK Signal Pathways in Rat Renal Mesangial Cells* , 1998, The Journal of Biological Chemistry.
[16] Y. Kimura,et al. Effects of stilbenes isolated from medicinal plants on arachidonate metabolism and degranulation in human polymorphonuclear leukocytes. , 1995, Journal of ethnopharmacology.
[17] Richard Graham Knowles,et al. Nitric oxide synthase activity in human gynecological cancer. , 1994, Cancer research.
[18] T. Slaga,et al. Increased expression of p50-NF-κB and constitutive activation of NF-κB transcription factors during mouse skin carcinogenesis , 1999, Oncogene.
[19] J. Baron,et al. Reduced risk of large-bowel adenomas among aspirin users. The Polyp Prevention Study Group. , 1993, Journal of the National Cancer Institute.
[20] C. Ho,et al. Inhibition of inducible nitric oxide synthase gene expression and enzyme activity by epigallocatechin gallate, a natural product from green tea. , 1997, Biochemical pharmacology.
[21] J. J. Moreno,et al. Effect of resveratrol, a natural polyphenolic compound, on reactive oxygen species and prostaglandin production. , 2000, Biochemical pharmacology.
[22] Dirk Bohmann,et al. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis , 1999, Oncogene.
[23] Hong Zhang,et al. NF-κB is required for H-ras oncogene induced abnormal cell proliferation and tumorigenesis , 2000, Oncogene.
[24] S. Snyder,et al. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. , 1994, Science.
[25] B. Rigas,et al. Altered eicosanoid levels in human colon cancer. , 1993, The Journal of laboratory and clinical medicine.
[26] A. Bennett,et al. The production of prostanoids in human cancers, and their implications for tumor progression. , 1986, Progress in lipid research.
[27] C. Harris,et al. Nitric oxide-induced p53 accumulation and regulation of inducible nitric oxide synthase expression by wild-type p53. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[28] G. Yu,et al. Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide: mediation through both mitogen-activated protein kinase and NF-kappaB signaling pathways in macrophages. , 1997, Biochemical pharmacology.
[29] H. Niiro,et al. MAP kinase pathways as a route for regulatory mechanisms of IL-10 and IL-4 which inhibit COX-2 expression in human monocytes. , 1998, Biochemical and biophysical research communications.
[30] R. Davis,et al. The mitogen-activated protein kinase signal transduction pathway. , 1993, The Journal of biological chemistry.
[31] A. Ianaro,et al. Modulation by nitric oxide of prostaglandin biosynthesis in the rat , 1995, British journal of pharmacology.
[32] Céline Gélinas,et al. Rel/NF-?B and I?B factors in oncogenesis , 1997 .
[33] G. De Nucci,et al. Prostaglandin E2 regulates inducible nitric oxide synthase in the murine macrophage cell line J774. , 1995, Prostaglandins.
[34] I. Adcock,et al. Evidence for Involvement of NF-κB in the Transcriptional Control of COX-2 Gene Expression by IL-1β ☆ , 1997 .
[35] H. Bernstein,et al. Role of nitric oxide and peroxynitrite in bile salt-induced apoptosis: relevance to colon carcinogenesis. , 1999, Nutrition and cancer.
[36] M. Rustin,et al. Arachidonic acid metabolites in cutaneous carcinomas. , 1987, Archives of dermatology.
[37] Marty W. Mayo,et al. TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.
[38] J. Pezzuto,et al. Resveratrol Inhibits Cyclooxygenase-2 Transcription and Activity in Phorbol Ester-treated Human Mammary Epithelial Cells* , 1998, The Journal of Biological Chemistry.
[39] M. Karin. The Regulation of AP-1 Activity by Mitogen-activated Protein Kinases (*) , 1995, The Journal of Biological Chemistry.
[40] J. Vilček,et al. Activation of p38 Mitogen-Activated Protein Kinase by Sodium Salicylate Leads to Inhibition of Tumor Necrosis Factor-Induced IκBα Phosphorylation and Degradation , 1998, Molecular and Cellular Biology.
[41] K. Min,et al. Inhibitory effects of resveratrol analogs on unopsonized zymosan-induced oxygen radical production. , 1999, Biochemical pharmacology.
[42] S. Han,et al. Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. , 1999, Clinical immunology.
[43] G. Bowden,et al. Increased ROS levels contribute to elevated transcription factor and MAP kinase activities in malignantly progressed mouse keratinocyte cell lines. , 1999, Carcinogenesis.
[44] J. Shah,et al. Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. , 1999, Cancer research.
[45] James B. Mitchell,et al. The multifaceted roles of nitric oxide in cancer. , 1998, Carcinogenesis.
[46] M. Alcaraz,et al. Co-regulation between cyclo-oxygenase-2 and inducible nitric oxide synthase expression in the time-course of murine inflammation , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.
[47] H. Nakano,et al. Differential regulation of IκB kinase α and β by two upstream kinases, NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1 , 1998 .
[48] W. Pryor,et al. Peroxynitrite causes DNA nicks in plasmid pBR322. , 1995, Biochemical and biophysical research communications.
[49] Y. Hara,et al. Antimutagenic and anticarcinogenic activity of tea polyphenols. , 1999, Mutation research.
[50] H. Umehara,et al. Requirement of AP-1 for Ceramide-induced Apoptosis in Human Leukemia HL-60 Cells (*) , 1995, The Journal of Biological Chemistry.
[51] G. Shklar,et al. Delay in hamster buccal pouch carcinogenesis by aspirin and indomethacin. , 1982, Oral surgery, oral medicine, and oral pathology.
[52] D. Gabuzda,et al. ERK MAP Kinase Links Cytokine Signals to Activation of Latent HIV-1 Infection by Stimulating a Cooperative Interaction of AP-1 and NF-κB* , 1999, The Journal of Biological Chemistry.
[53] H. Mukhtar,et al. Polyphenols as cancer chemopreventive agents , 1995, Journal of cellular biochemistry. Supplement.
[54] J. Lin,et al. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. , 1999, Biochemical pharmacology.
[55] Bruno C. Hancock,et al. Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.
[56] A. Conney,et al. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. , 1991, Cancer research.
[57] H. Yun,et al. Hepatic ischemia/reperfusion in rats induces iNOS gene transcription by activation of NF-kappaB. , 1999, Biochemical and biophysical research communications.
[58] W C Willett,et al. Aspirin and the risk of colorectal cancer in women. , 1995, The New England journal of medicine.
[59] F Yang,et al. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. , 1998, The Journal of nutrition.
[60] Y. Vodovotz,et al. Superoxide Modulates the Oxidation and Nitrosation of Thiols by Nitric Oxide-derived Reactive Intermediates , 1997, The Journal of Biological Chemistry.
[61] M. Currie,et al. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors. , 1999, The Journal of rheumatology.
[62] J. Albina,et al. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. , 1993, Journal of immunology.
[63] Y. Yatabe,et al. Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. , 1998, Cancer research.
[64] C. Paraskeva,et al. Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[65] T. Sugimura,et al. Suppression of cyclooxygenase-2 promoter-dependent transcriptional activity in colon cancer cells by chemopreventive agents with a resorcin-type structure. , 2000, Carcinogenesis.
[66] T. Ogihara,et al. Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.
[67] T. Chiles,et al. Transient stimulation of the c-Jun-NH2-terminal kinase/activator protein 1 pathway and inhibition of extracellular signal-regulated kinase are early effects in paclitaxel-mediated apoptosis in human B lymphoblasts. , 1998, Cancer research.
[68] E. Manos,et al. Inhibition of MAP kinase kinase (MEK) results in an anti-inflammatory response in vivo. , 2000, Biochemical and biophysical research communications.
[69] M. Karin,et al. Mitogen-activated protein kinase cascades and regulation of gene expression. , 1996, Current opinion in immunology.
[70] Richard Graham Knowles,et al. Nitric oxide synthase activity in human breast cancer. , 1995, British Journal of Cancer.
[71] C. Rice-Evans,et al. Inhibition of peroxynitrite-mediated tyrosine nitration by catechin polyphenols. , 1997, Biochemical and biophysical research communications.
[72] S. Tannenbaum,et al. DNA damage and mutation in human cells exposed to nitric oxide in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[73] C. Rao,et al. Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. , 1999, Carcinogenesis.
[74] R. DuBois,et al. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. , 1996, Gastroenterology.
[75] C. Ho,et al. Effects of three dietary phytochemicals from tea, rosemary and turmeric on inflammation-induced nitrite production. , 1995, Cancer letters.
[76] J. Inoue,et al. MEK Kinase Is Involved in Tumor Necrosis Factor α-Induced NF-κB Activation and Degradation of IκB-α* , 1996, The Journal of Biological Chemistry.
[77] R. Cooney,et al. Inhibitors of endogenous nitrogen oxide formation block the promotion of neoplastic transformation in C3H 10T1/2 fibroblasts. , 1993, Carcinogenesis.
[78] M. Delong,et al. Temporal effects of the detoxification enzyme inducer, benzyl isothiocyanate: activation of c-Jun N-terminal kinase prior to the transcription factors AP-1 and NFkappaB. , 1999, Biochemical and biophysical research communications.
[79] B. Aggarwal,et al. Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. , 1997, Anti-Cancer Drugs.
[80] H. Mukhtar,et al. Mechanism of cancer chemopreventive activity of green Tea. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[81] D. Tobin,et al. Ras-independent activation of Rel-family transcription factors by UVB and TPA in cultured keratinocytes. , 1996, Oncogene.
[82] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[83] Wan-Wan Lin,et al. Induction of cyclo‐oxygenase‐2 expression by methyl arachidonyl fluorophosphonate in murine J774 macrophages: roles of protein kinase C, ERKs and p38 MAPK , 1999, British journal of pharmacology.
[84] Kei Yamamoto,et al. Transcriptional Roles of Nuclear Factor B and Nuclear Factor-Interleukin-6 in the Tumor Necrosis Factor -Dependent Induction of Cyclooxygenase-2 in MC3T3-E1 Cells (*) , 1995, The Journal of Biological Chemistry.
[85] N. Altorki,et al. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. , 1999, Carcinogenesis.
[86] T. Yasuda,et al. Molecular mechanisms of apoptosis in HL-60 cells induced by a nitric oxide-releasing compound. , 1997, Free radical research.
[87] Han,et al. Specific NF‐κB blockade selectively inhibits tumour necrosis factor‐α‐induced COX‐2 but not constitutive COX‐1 gene expression in HT‐29 cells , 1998, Immunology.
[88] Xianglin Shi,et al. Vanadate Induction of NF-κB Involves IκB Kinase β and SAPK/ERK Kinase 1 in Macrophages* , 1999, The Journal of Biological Chemistry.
[89] A. Ford-hutchinson,et al. Expression of mRNA for cyclooxygenase‐1 and cyclooxygenase‐2 in human tissues , 1993, FEBS letters.
[90] S Amerini,et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.
[91] M. Karin,et al. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action? , 1998 .
[92] S. Kawanishi,et al. Oxidative DNA damage induced by simultaneous generation of nitric oxide and superoxide , 1995, FEBS letters.
[93] G. Sonenshein. Rel/NF-κB transcription factors and the control of apoptosis , 1997 .
[94] Richard E. White,et al. Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: reversal of endothelin‐1 stimulatory effects , 1999, FEBS letters.
[95] T. Billiar,et al. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. , 1991, Journal of immunology.
[96] M. Lindsay,et al. Superinduction of COX‐2 mRNA by cycloheximide and interleukin‐1β involves increased transcription and correlates with increased NF‐κB and JNK activation , 1997, FEBS letters.
[97] C. Szabó,et al. DNA damage induced by peroxynitrite: subsequent biological effects. , 1997, Nitric oxide : biology and chemistry.
[98] Masao Tanaka,et al. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-κB activation , 2000, Oncogene.
[99] H. Maeda,et al. Nitric oxide and oxygen radicals in infection, inflammation, and cancer. , 1998, Biochemistry. Biokhimiia.
[100] M. Runge,et al. Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.
[101] D. Heilman,et al. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas. , 2000, Carcinogenesis.
[102] G. T. Bowden,et al. (-)-Epigallocatechin-3-gallate inhibition of ultraviolet B-induced AP-1 activity. , 1998, Carcinogenesis.
[103] R. Langenbach,et al. Malignant Transformation and Antineoplastic Actions of Nonsteroidal Antiinflammatory Drugs (Nsaids) on Cyclooxygenase-Null Embryo Fibroblasts , 1999, The Journal of experimental medicine.
[104] M. Barinaga. Life-Death Balance Within the Cell , 1996, Science.
[105] D. Karunagaran,et al. L-929 Cells Harboring Ectopically Expressed RelA Resist Curcumin-induced Apoptosis* , 2000, The Journal of Biological Chemistry.
[106] J. Vane,et al. Co‐induction of nitric oxide synthase and cyclo‐oxygenase: interactions between nitric oxide and prostanoids , 1995, British journal of pharmacology.
[107] Weiya Ma,et al. Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (-)-epigallocatechin gallate, and theaflavins. , 1997, Cancer research.
[108] Y. P. Lu,et al. Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. , 1993, Carcinogenesis.
[109] A. Morrison,et al. Antioxidants Inhibit Interleukin-1-induced Cyclooxygenase and Nitric-oxide Synthase Expression in Rat Mesangial Cells , 1996, The Journal of Biological Chemistry.
[110] Andrew J. Dannenberg,et al. Inhibition of Cyclooxygenase: A Novel Approach to Cancer Prevention , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[111] S Jothy,et al. Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. , 1995, Cancer research.
[112] Sharon R. Adderley,et al. Oxidative Damage of Cardiomyocytes Is Limited by Extracellular Regulated Kinases 1/2-mediated Induction of Cyclooxygenase-2* , 1999, The Journal of Biological Chemistry.
[113] T. Sugimura,et al. Increased expression of inducible and endothelial constitutive nitric oxide synthases in rat colon tumors induced by azoxymethane. , 1997, Cancer research.
[114] D. Mccormick,et al. Modulation of rat mammary carcinogenesis by indomethacin. , 1985, Cancer research.
[115] R. Hall,et al. Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. , 1999, Arteriosclerosis, thrombosis, and vascular biology.
[116] K. Imaida,et al. Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine. , 1990, Carcinogenesis.
[117] M. Rosa,et al. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774 , 1992, British journal of pharmacology.
[118] H. Herschman,et al. v-src Induces Prostaglandin Synthase 2 Gene Expression by Activation of the c-Jun N-terminal Kinase and the c-Jun Transcription Factor (*) , 1995, The Journal of Biological Chemistry.
[119] K. Seibert,et al. Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase‐2 , 1998, Molecular carcinogenesis.
[120] K. Schrör,et al. Cyclooxygenase-2 expression in human esophageal carcinoma. , 1999, Cancer research.
[121] P. Barnes,et al. Sodium salicylate inhibits cyclo-oxygenase-2 activity independently of transcription factor (nuclear factor kappaB) activation: role of arachidonic acid. , 1997, Molecular pharmacology.
[122] Y. Surh,et al. Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. , 1999, Mutation research.
[123] T. Tan,et al. Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin , 1998, Oncogene.
[124] J. Russo,et al. Activation of NF-kappaB/Rel occurs early during neoplastic transformation of mammary cells. , 2000, Carcinogenesis.
[125] Douglas B. Evans,et al. The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .
[126] T. Sugimura,et al. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. , 2000, Carcinogenesis.
[127] H. Tajiri,et al. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells , 1997, Oncogene.
[128] R. Kuttan,et al. Inhibition of chemical carcinogenesis by curcumin. , 1989, Journal of ethnopharmacology.
[129] H. Sato,et al. Activation of matrix metalloproteinase‐2 in human breast cancer cells overexpressing cyclooxygenase‐1 or ‐2 , 1999, FEBS letters.
[130] J. Vane,et al. Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.
[131] K. Subbaramaiah,et al. Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. , 1996, Cancer research.
[132] E. Cerise,et al. Sulindac for polyposis of the colon. , 1989, American journal of surgery.
[133] F. D’Acquisto,et al. Evidence that inducible nitric oxide synthase is involved in LPS‐induced plasma leakage in rat skin through the activation of nuclear factor‐κB , 1998, British journal of pharmacology.
[134] Michael E. Greenberg,et al. Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.
[135] C. Nathan,et al. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.
[136] V. Steele,et al. Chemoprevention of Colon Carcinogenesis by Sulindac , a Nonsteroidal Anti-inflammatory Agent 1 , 2022 .
[137] Y. Kotake,et al. Inhibition of NF-kappaB, iNOS mRNA, COX2 mRNA, and COX catalytic activity by phenyl-N-tert-butylnitrone (PBN). , 1998, Biochimica et biophysica acta.
[138] H. Ciolino,et al. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. , 1998, Cancer research.
[139] S. Padmaja,et al. The reaction of no with superoxide. , 1993, Free radical research communications.
[140] J. Mazuski,et al. The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells. , 2000, Carcinogenesis.
[141] D. Pérez-Sala,et al. Dual effect of nitric oxide donors on cyclooxygenase-2 expression in human mesangial cells. , 1999, Journal of the American Society of Nephrology : JASN.
[142] P Rhodes,et al. Roles of nitric oxide in tumor growth. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[143] J. Morrow,et al. A selective cyclooxygenase 2 inhibitor suppresses the growth of H-ras-transformed rat intestinal epithelial cells. , 1997, Gastroenterology.
[144] Keunchil Park,et al. Mechanistic Aspects of Green Tea as a Cancer Preventive: Effect of Components on Human Stomach Cancer Cell Lines , 1999, Japanese journal of cancer research : Gann.
[145] B. Aggarwal,et al. Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. , 1998, The Journal of biological chemistry.
[146] G. Zhou,et al. c-Jun N-terminal kinase mediates apoptotic signaling induced by N-(4-hydroxyphenyl)retinamide. , 1999, Molecular pharmacology.
[147] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[148] F. Guengerich,et al. Resveratrol is a selective human cytochrome P450 1A1 inhibitor. , 1999, Biochemical and biophysical research communications.
[149] H. Sheng,et al. Induction of Cyclooxygenase-2 by Activated Ha-rasOncogene in Rat-1 Fibroblasts and the Role of Mitogen-activated Protein Kinase Pathway* , 1998, The Journal of Biological Chemistry.
[150] Y. Surh,et al. Anti-tumor promoting potential of naturally occurring diarylheptanoids structurally related to curcumin. , 1999, Mutation research.
[151] K. Knudtson,et al. The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP). , 1999, The Journal of biological chemistry.
[152] S. Meltzer,et al. Advances in Brief Increased Expression of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Barrett ' s Esophagus and Associated Adenocarcinomas 1 , 2006 .
[153] G. Wogan,et al. Mutagenesis associated with nitric oxide production in macrophages. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[154] S. Kakar,et al. Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. , 1994, Cancer letters.
[155] G. Piazza,et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction. , 1997, Cancer research.
[156] Y. Ho,et al. Mechanisms of cell death induced by nitric oxide and peroxynitrite in Calu-1 cells. , 1998, Environmental toxicology and pharmacology.
[157] Jen-kun Lin,et al. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. , 1993, Carcinogenesis.
[158] T. Żebro,et al. PROSTAGLANDINS AND BREAST CANCER , 1977, The Lancet.
[159] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[160] V. Steele,et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. , 2000, Cancer research.
[161] Jen-kun Lin,et al. Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. , 1996, Nutrition and cancer.
[162] N. Colburn,et al. Expression of dominant negative Jun inhibits elevated AP-1 and NF-κB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes , 1998, Oncogene.
[163] M. Miloso,et al. Resveratrol-induced activation of the mitogen-activated protein kinases, ERK1 and ERK2, in human neuroblastoma SH-SY5Y cells , 1999, Neuroscience Letters.
[164] J. Morrow,et al. Peroxynitrite, the coupling product of nitric oxide and superoxide, activates prostaglandin biosynthesis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[165] G. Kelloff,et al. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. , 1993, Carcinogenesis.
[166] B. Brüne,et al. p53 expression in nitric oxide‐induced apoptosis , 1994, FEBS letters.
[167] L. Marnett,et al. Arachidonic Acid Oxygenation by COX-1 and COX-2 , 1999, The Journal of Biological Chemistry.
[168] Jen-kun Lin,et al. (−)-Epigallocatechin-3-gallate Blocks the Induction of Nitric Oxide Synthase by Down-Regulating Lipopolysaccharide-Induced Activity of Transcription Factor Nuclear Factor-κB , 1997 .
[169] R. Yu,et al. Signal transduction events elicited by natural products: Role of MAPK and caspase pathways in homeostatic response and induction of apoptosis , 2000, Archives of pharmacal research.
[170] G. Levi,et al. Prostaglandin E2 synthesis is differentially affected by reactive nitrogen intermediates in cultured rat microglia and RAW 264.7 cells , 1997, FEBS letters.
[171] Chi-Tang Ho,et al. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. , 1998, Cancer letters.
[172] M. Taketo,et al. COX-2 and colon cancer , 1998, Inflammation Research.
[173] K. Kinzler,et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[174] S. Gupta,et al. Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. , 2000, Archives of biochemistry and biophysics.
[175] Xianglin Shi,et al. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. , 1999, Clinical chemistry.
[176] T. Inoue,et al. Cyclooxygenase inhibitors enhance the production of tissue inhibitor-1 of metalloproteinases (TIMP-1) and pro-matrix metalloproteinase 1 (proMMP-1) in human rheumatoid synovial fibroblasts , 1997, Inflammation Research.
[177] G. Yang,et al. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. , 1998, Carcinogenesis.
[178] Jia-Ling Yang,et al. Roles of JNK, p38 and ERK mitogen-activated protein kinases in the growth inhibition and apoptosis induced by cadmium. , 2000, Carcinogenesis.
[179] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.
[180] I. Adcock,et al. Oxidative Stress Induces NFκB DNA Binding and Inducible NOS mRNA in Human Epithelial Cells , 1994 .
[181] B. Rigas,et al. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. , 1995, Biochimica et biophysica acta.
[182] T. Taniguchi,et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.
[183] C. Harris,et al. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. , 1998, Cancer research.
[184] Weiya Ma,et al. Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced NF-kappaB activation by tea polyphenols, (-)-epigallocatechin gallate and theaflavins. , 2000, Carcinogenesis.
[185] G. Loo,et al. Effects of epigallocatechin gallate and quercetin on oxidative damage to cellular DNA. , 2000, Mutation research.
[186] H. Ammon,et al. Pharmacology of Curcuma longa , 1991, Planta medica.
[187] C. Shih,et al. Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NJH3T3 cells , 1994 .
[188] S. Manna,et al. Resveratrol Suppresses TNF-Induced Activation of Nuclear Transcription Factors NF-κB, Activator Protein-1, and Apoptosis: Potential Role of Reactive Oxygen Intermediates and Lipid Peroxidation1 , 2000, The Journal of Immunology.
[189] F. Marks,et al. Differential expression of prostaglandin h synthase isozymes during multistage carcinogenesis in mouse epidermis , 1995, Molecular carcinogenesis.
[190] J. Mitchell,et al. Cyclo‐oxygenase and nitric oxide synthase isoforms in rat carrageenin‐induced pleurisy , 1994, British journal of pharmacology.
[191] N. Holbrook,et al. The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. , 1998, The Biochemical journal.
[192] R. Weaver,et al. Human mitogen-activated protein kinase kinase kinase mediates the stress-induced activation of mitogen-activated protein kinase cascades. , 1998, The Biochemical journal.
[193] A. von Knethen,et al. Cyclooxygenase‐2: an essential regulator of NO‐mediated apoptosis , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[194] F. Robertson,et al. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. , 1996, Carcinogenesis.
[195] K. Piwocka,et al. Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. , 1997, Biochemical pharmacology.
[196] Y. P. Lu,et al. Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. , 1994, Carcinogenesis.
[197] S. Moncada,et al. Human colorectal adenocarcinoma cells: differential nitric oxide synthesis determines their ability to aggregate platelets. , 1991, Cancer research.
[198] Norman R. Farnsworth,et al. Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes , 1997, Science.
[199] T. Billiar,et al. Endogenous nitric oxide inhibits the synthesis of cyclooxygenase products and interleukin‐6 by rat Kupffer cells , 1993, Journal of leukocyte biology.
[200] A. Baldwin,et al. Chemopreventive properties of trans-resveratrol are associated with inhibition of activation of the IkappaB kinase. , 2000, Cancer research.
[201] Jen-kun Lin,et al. Suppression of extracellular signals and cell proliferation through EGF receptor binding by (−)‐epigallocatechin gallate in human A431 epidermoid carcinoma cells , 1997, Journal of cellular biochemistry.
[202] H. Ciolino,et al. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. , 1999, Molecular pharmacology.
[203] S. Tannenbaum,et al. Nitric oxide induces oxidative damage in addition to deamination in macrophage DNA. , 1995, Chemical research in toxicology.
[204] Z. Brown,et al. p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.
[205] A. Komori,et al. A new tumor promotion pathway and its inhibitors. , 1994, Cancer detection and prevention.
[206] C. Han,et al. Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice. , 1995, Nutrition and cancer.
[207] K. C. Srivastava,et al. Curcumin, a major component of food spice turmeric (Curcuma longa) inhibits aggregation and alters eicosanoid metabolism in human blood platelets. , 1995, Prostaglandins, leukotrienes, and essential fatty acids.
[208] R. Agarwal,et al. Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. , 1997, Journal of the National Cancer Institute.
[209] Y. Yun,et al. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). , 1999, Molecular biology of the cell.
[210] L. Howells,et al. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-κB activation via the NIK/IKK signalling complex , 1999, Oncogene.
[211] Weiya Ma,et al. Inhibition of Ultraviolet B–Induced AP‐1 Activation by Theaflavins From Black Tea , 2000, Molecular carcinogenesis.
[212] J. Kanner,et al. Nitric oxide as an antioxidant. , 1991, Archives of biochemistry and biophysics.
[213] Michael Karin,et al. Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.
[214] D. Koop,et al. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. , 1999, Biochemical pharmacology.
[215] M. Favata,et al. Inhibition of MAP kinase kinase prevents cytokine and prostaglandin E2 production in lipopolysaccharide-stimulated monocytes. , 1998, Journal of immunology.
[216] Chung S. Yang. Inhibition of carcinogenesis by tea , 1997, Nature.
[217] S. Ghosh,et al. Inhibition of NF-kappa B by sodium salicylate and aspirin. , 1994, Science.
[218] M. Chan,et al. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. , 1998, Biochemical pharmacology.
[219] K. Skorecki,et al. Induction of Cytosolic Phospholipase A2 by Oncogenic Ras in Human Non-small Cell Lung Cancer* , 1997, The Journal of Biological Chemistry.
[220] M. Kondo,et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.
[221] R. Srimal,et al. Pharmacology of diferuloyl methane (curcumin), a non‐steroidal anti‐inflammatory agent * , 1973, The Journal of pharmacy and pharmacology.
[222] N. Swanson,et al. Arachidonic acid metabolites in cutaneous carcinomas. Evidence suggesting that elevated levels of prostaglandins in basal cell carcinomas are associated with an aggressive growth pattern. , 1986, Archives of dermatology.
[223] C. Young,et al. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. , 1998, Cancer letters.
[224] A. Shah,et al. Synergy between ethanol and grape polyphenols, quercetin, and resveratrol, in the inhibition of the inducible nitric oxide synthase pathway. , 2000, Biochemical pharmacology.
[225] R. Teel,et al. Modulation by phytochemicals of cytochrome P450-linked enzyme activity. , 1998, Cancer letters.
[226] G. Bowden,et al. Inhibition of ultraviolet B–induced c‐fos gene expression and p38 mitogen‐activated protein kinase activation by (‐)‐epigallocatechin gallate in a human keratinocyte cell line , 1999, Molecular carcinogenesis.
[227] R. Everson,et al. Aspirin Use and Lung, Colon, and Breast Cancer Incidence in a Prospective Study , 1994, Epidemiology.
[228] B. Rigas,et al. Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. , 1997, The Journal of laboratory and clinical medicine.
[229] F. D’Acquisto,et al. Involvement of NF‐κB in the regulation of cyclooxygenase‐2 protein expression in LPS‐stimulated J774 macrophages , 1997, FEBS letters.
[230] V. Anderson,et al. A stable solid that generates hydroxyl radical upon dissolution in aqueous solutions: reaction with proteins and nucleic acid , 1992 .
[231] R. DuBois,et al. The role of nonsteroidal anti-inflammatory drugs in colorectal cancer prevention. , 1995, European journal of cancer.
[232] A. Murakami,et al. Inhibitory Effects of Curcumin and Tetrahydrocurcuminoids on the Tumor Promoter‐induced Reactive Oxygen Species Generation in Leukocytes in vitro and in vivo , 1998, Japanese journal of cancer research : Gann.
[233] S. Piantadosi,et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. , 1993, The New England journal of medicine.
[234] T. Fahey,et al. Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. , 1999, Cancer research.
[235] J. Lin,et al. Inhibitory effects of phytopolyphenols on TPA-induced transformation, PKC activation, and c-jun expression in mouse fibroblast cells. , 1997, Nutrition and cancer.
[236] Y. Lou,et al. Some Perspectives on Dietary Inhibition of Carcinogenesis: Studies with Curcumin and Tea , 1997, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[237] D. Brenner,et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. , 1999, Journal of immunology.
[238] R. Davis,et al. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways , 1996, Journal of Molecular Medicine.
[239] M. Bertagnolli,et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. , 1996, Cancer research.
[240] B. Levin,et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. , 2000, The New England journal of medicine.
[241] H. Fujiki,et al. Green tea and cancer chemoprevention. , 1999, Mutation research.
[242] R. DuBois,et al. Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[243] R. White,et al. Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[244] F. Sun,et al. Reactive oxygen species participate in peroxynitrite-induced apoptosis in HL-60 cells. , 1997, Biochemical and biophysical research communications.
[245] Jen-kun Lin,et al. Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. , 1996, Oncogene.
[246] K. Wu,et al. Cyclooxygenase 2 induction: molecular mechanism and pathophysiologic roles. , 1996, The Journal of laboratory and clinical medicine.
[247] L. Ignarro,et al. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. , 1981, The Journal of pharmacology and experimental therapeutics.
[248] G. Nisticó,et al. NMDA-dependent prostaglandin E2 release by human cultured astroglial cells is driven by nitric oxide. , 1995, Biochemical and biophysical research communications.
[249] C. Williams,et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis , 1993, The British journal of surgery.
[250] A. Castonguay,et al. Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols. , 1997, Carcinogenesis.
[251] J. Williams,et al. Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[252] B. Aggarwal,et al. Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane) (*) , 1995, The Journal of Biological Chemistry.
[253] K. Seibert,et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase‐2 inhibitor, and indomethacin against ultraviolet light–induced skin carcinogenesis , 1999, Molecular carcinogenesis.
[254] S. Seki,et al. Effect of antioxidants, resveratrol, quercetin, and N‐acetylcysteine, on the functions of cultured rat hepatic stellate cells and kupffer cells , 1998, Hepatology.
[255] Seamus J. Martin,et al. Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.
[256] R. DuBois,et al. Prostaglandin endoperoxide synthase: why two isoforms? , 1996, The American journal of physiology.
[257] H. Ohshima,et al. Formation of 8‐nitroguanine in DNA treated with peroxynitrite in vitro and its rapid removal from DNA by depurination , 1995, FEBS letters.
[258] M. Watabe,et al. Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells , 1998, Oncogene.
[259] J. Pezzuto,et al. Effects of resveratrol on 12-O-tetradecanoylphorbol-13-acetate-induced oxidative events and gene expression in mouse skin. , 1998, Cancer letters.
[260] A. Hsu,et al. The Cyclooxygenase-2 Inhibitor Celecoxib Induces Apoptosis by Blocking Akt Activation in Human Prostate Cancer Cells Independently of Bcl-2* , 2000, The Journal of Biological Chemistry.
[261] Jen-kun Lin,et al. A labile hyperphosphorylated c-Fos protein is induced in mouse fibroblast cells treated with a combination of phorbol ester and anti-tumor promoter curcumin. , 1995, Cancer letters.
[262] H. Jiang,et al. Diffusion of peroxynitrite into the human platelet inhibits cyclooxygenase via nitration of tyrosine residues. , 2000, The Journal of pharmacology and experimental therapeutics.
[263] B. Freeman,et al. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[264] Z. Dong,et al. Inhibition of activator protein 1 activity and cell growth by purified green tea and black tea polyphenols in H-ras-transformed cells: structure-activity relationship and mechanisms involved. , 1999, Cancer research.
[265] David Baltimore,et al. An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.
[266] C. Nathan,et al. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.
[267] H. Granger,et al. Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.
[268] Jen-kun Lin,et al. Suppression of nitric oxide synthase and the down‐regulation of the activation of NFκB in macrophages by resveratrol , 1999, British journal of pharmacology.
[269] M. Kitamura,et al. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. , 2000, Kidney international.
[270] M. Sporn,et al. Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. , 1998, Cancer research.
[271] Jiahuai Han,et al. Cell Stress and MKK6b-mediated p38 MAP Kinase Activation Inhibit Tumor Necrosis Factor-induced IκB Phosphorylation and NF-κB Activation* , 1999, The Journal of Biological Chemistry.
[272] T. Maniatis,et al. Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.
[273] W. Whimster,et al. Prostaglandins and human lung carcinomas. , 1982, British Journal of Cancer.
[274] N. Blough,et al. REACTION OF SUPEROXIDE WITH NITRIX OXIDE TO FORM PEROXYNITRITE IN ALKALINE AQUEOUS SOLUTION , 1995 .
[275] Jen-kun Lin,et al. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[276] N. Blough,et al. Reaction of superoxide with nitric oxide to form peroxonitrite in alkaline aqueous solution , 1985 .
[277] I. Macara,et al. Persistent induction of cyclooxygenase in p60v-src-transformed 3T3 fibroblasts. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[278] H. Ohshima,et al. Formation of 8-nitroguanine by the reaction of guanine with peroxynitrite in vitro. , 1995, Carcinogenesis.
[279] N. Colburn,et al. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. , 1997, Cancer research.
[280] S. Bhide,et al. Curcumin as an inhibitor of cancer. , 1992, Journal of the American College of Nutrition.
[281] M. Currie,et al. Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors. , 1995, The Journal of clinical investigation.
[282] M. Mcdaniel,et al. IL-1 beta induces the coexpression of both nitric oxide synthase and cyclooxygenase by islets of Langerhans: activation of cyclooxygenase by nitric oxide. , 1993, Biochemistry.
[283] M. Currie,et al. Nitric oxide activates cyclooxygenase enzymes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[284] A. Ristimäki,et al. Expression of cyclooxygenase-2 in human gastric carcinoma. , 1997, Cancer research.
[285] M. Miller,et al. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. , 1997, Gastroenterology.
[286] K. H. Lee,et al. NF-kappaB-dependent expression of nitric oxide synthase is required for membrane fusion of chick embryonic myoblasts. , 1997, The Biochemical journal.
[287] R. Yu,et al. Activation of mitogen-activated protein kinases by green tea polyphenols: potential signaling pathways in the regulation of antioxidant-responsive element-mediated phase II enzyme gene expression. , 1997, Carcinogenesis.
[288] Y. Lee,et al. Inhibition of activation of nuclear factor kappaB is responsible for inhibition of inducible nitric oxide synthase expression by higenamine, an active component of aconite root. , 1999, The Journal of pharmacology and experimental therapeutics.
[289] B. Pardhasaradhi,et al. Curcumin mediated apoptosis in AK‐5 tumor cells involves the production of reactive oxygen intermediates , 1999, FEBS letters.
[290] D. Wallach,et al. MAP3K-related kinase involved in NF-KB induction by TNF, CD95 and IL-1 , 1997, Nature.
[291] C. Der,et al. Oncogenic Ha-Ras-induced Signaling Activates NF-κB Transcriptional Activity, Which Is Required for Cellular Transformation* , 1997, The Journal of Biological Chemistry.
[292] L. Marnett. Aspirin and the potential role of prostaglandins in colon cancer. , 1992, Cancer research.
[293] H. Ohshima,et al. Antioxidant and pro-oxidant actions of flavonoids: effects on DNA damage induced by nitric oxide, peroxynitrite and nitroxyl anion. , 1998, Free radical biology & medicine.